EMA During a virtual meeting held on 2nd April 2020, EMA’s human medicines committee (CHMP) gave recommendations on how to use the investigational antiviral medicine, Remdesivir for treating coronavirus disease (COVID-19) in compassionate use programmes in the European Union. Remdesivir has been shown to be active against SARS-CoV-2 and other types of coronavirus (i.e. SARS-CoV and MERS-CoV)…
A Group Discussion or GD evaluates the qualities of a person. It assesses the leadership skills, social skills, team skills, problem-solving skills and presence of mind in an individual. Group Discussion is an energized discussion where a topic is examined and discussed, and in the end, the participants come to…
India has found immense success in fighting life-threatening diseases like tuberculosis, malaria, lymphatic filariasis, and more. With such success, the country is all set to play a vital role in determining whether new drugs, vaccines, and other prevention tools can be deployed effectively and affordably to eliminate all such diseases…
Diabetes is one of the most common health issues that people all over the world are encountering. Speaking of India, the country sees 10% of the total population suffering from diabetes. But, the shocking fact here is that almost one in every two Indians living with diabetes is unaware of…
India is home to 1/4th of the world’s tuberculosis burden, which has given the country an opportunity to make huge strides in public health by becoming a global leader in tuberculosis research. Taking this initiative, a vaccine trial was launched on 15th of July 2019 by the Indian Council of…
Every year, more than 40 lakh people across the globe die within 30 days of a surgical operation! And, half of these deaths occur in low and middle income countries. India is one such country on the list. But, what is the main reason behind such deaths? It is Surgical…
The drug policy in India had been framed and the rules had been formulated under the Drugs and Cosmetics Act, 1945, which aimed to provide essential pharmaceutical products at reasonable prices, and facilitate original produce at cost-effective prices without a compromise on quality, while also facilitating export of pharmaceuticals by…
On 19th March 2019, the Union Ministry for Health and Family Welfare declared the new Drugs And Clinical Trials Rules 2019, which aim to promote clinical research in India through transparent and faster approval processes. These new rules are applicable to all new drugs intended for clinical trials, bioequivalence study,…
In 2013, there were only 17 clinical trials approved by the Drug Controller General of India. But, the number has slowly increased over the years, and by the year 2017, it reached to 97, which signifies a huge jump of more than 400% in a period of five years. The…
